Vinorelbine
A case of malignant mesothelioma presenting with recurrent pneumothorax
Nihon Kokyuki Gakkai Zasshi. 2006 Nov;44(11):807-11. [Link] Katayam N, Tokuda A, Nakatsumi Y, Oribe Y, Fujimura M. Department of Respiratory Medicine, Kanazawa Municipal Hospital. Abstract A 71-year-old man was found to have right hydropneumothorax by chest X-ray film on a regular checkup. Thoracic drainage and bullectomy by thoracoscopy did not improve the pneumothorax, so pleurodesis…
Read MoreTriplet Chemotherapy for Malignant Pericardial Mesothelioma: A Case Report
Japanese Journal of Clinical Oncology. 2006 Mar 13; [Epub ahead of print] [Link] Maruyama R, Sakai M, Nakamura T, Suemitsu R, Okamoto T, Wataya H, Nishiyama K, Kamei T, Ichinose Y. Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan. Abstract Malignant pericardial mesothelioma (MPM) is a relatively rare neoplasm in Japan, and no standard…
Read MoreMesothelioma: advances in chemotherapy
Revue des Maladies Respiratoire. 2005 Dec;22(6-C2):49-54. [Link] Jacoulet P. Service de Pneumologie, CHU, Besancon, France. Abstract Chemotherapy is often the only treatment possible for locally advanced or metastatic mesothelioma. This paper recalls which drugs might have therapeutic benefits in this condition and reviews recent studies of chemotherapy or targeted therapy. If the patient cannot be…
Read MorePrognostic factors in mesothelioma
Lung Cancer. 2005 Jul;49 Suppl 1:S49-52. [Link] Steele JP, Klabatsa A, Fennell DA, Pallaska A, Sheaff MT, Evans MT, Shamash J, Rudd RM. Mesothelioma Unit, Department of Medical Oncology, St. Bartholomew’s Hospital and Medical College, London EC1A 7BE, UK. jeremy.steele@bartsandthelondon.nhs.uk Abstract Prognostic factors can help clinicians and patients when deciding a treatment plan. Patients in…
Read More